Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Information to shareholders: statutory migration

13 Oct 2025 15:30

RNS Number : 1582D
B&M European Value Retail S.A.
13 October 2025
 

B&M European Value Retail S.A.

3, rue Gabriel Lippmann, L-5365 Munsbach,

Luxembourg.

 

13 October 2025

 

Information to shareholders in relation to Shareholding and Settlement Arrangements post Migration

B&M European Value Retail S.A. ("B&M Luxembourg" or the "Company") is pleased to provide further information to shareholders regarding the statutory Migration pursuant to which it will become, in law, B&M European Value Retail plc ("B&M Jersey"), a public limited company governed by the laws of Jersey and will cease to be a société anonyme ("S.A.") incorporated under the Laws of Luxembourg. 

Position regarding shareholdings prior to and following the Migration

Currently, the majority of the shareholders hold their shares either in the form of CREST Depository Interests ("CDIs") or indirectly through a broker, nominee or other custodian account with Euroclear. It is expected that the vast majority of the Company's existing shareholders will not need to take any action as a consequence of the Migration and that they will be able to continue to hold their interest in the Company's shares and to receive dividends in the same way as they do at the moment.

Dividend Mandates

Existing dividend mandates in respect of B&M Luxembourg shares will continue to be effective in relation to shares in B&M Jersey for all existing shareholders provided that any shareholders holding through CREST have enabled their CREST memorandum account to accept dividend payments via the CREST system in relation to their holdings.

Where can you find further information?

The Company has prepared an FAQ document for shareholders, which is available on the Company's website. Shareholders are advised to read the FAQ Document carefully to ensure that they understand the arrangements that will apply to them following the Migration being completed and the actions, if any, that they may wish to take.

Further updates on the Migration process

In anticipation of the Migration, an application will be made for admission of the B&M Jersey shares to the equity shares (commercial companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange ("LSE") in place of the B&M Luxembourg shares, upon completion of the Migration (together, the "Admission"). Subject to certain regulatory approvals, it is expected that Admission and unconditional dealings in B&M Jersey shares will become effective after the publication of B&M Luxembourg's interim results on 13 November 2025 and prior to the end of this calendar year.

A new International Securities Identification Number ("ISIN"), JE00BVSYJW51, has been issued in respect of the B&M Jersey shares and will become effective upon the Migration being completed and Admission becoming effective.

A prospectus relating to the Admission is expected to be published by the Company shortly before Admission becomes effective. An announcement will be made at the relevant time via the LSE Regulatory News Service ("RNS") notifying shareholders that the prospectus has been published and that a copy of it is available for inspection on the Company's website.

Disclaimer and Important Information

The information set out in this announcement is for informational purposes only and is not, and is not to be construed as being, legal, business, financial or tax advice. If you are in any doubt the contents of this announcement or the action you should take or any potential tax consequences relating to any changes in the way in which you hold your Shares, you should consult your own appropriately authorised legal adviser, financial adviser or tax adviser.

If you hold your shares through a nominee, broker, custodian, trustee or in an ISA then you should also consult the relevant nominee, broker, custodian, trustee or ISA provider for assistance.

Enquiries

 

B&M European Value Retail S.A.

For further information please contact: +44 (0) 151 728 5400

Alexander Simpson

Group General Counsel

 

Andrew Orchard

Head of Investor Relations 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOASRVOURAAA
Date   Source Headline
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.